In their study of MET-altered lung cancer and gastrointestinal cancer cell lines, Saigi et al. reported that MET activation induced PD-L1 expression independently of the IFNγ-JAK2 pathway [20]. The gene discussed is CD274; the disease is lung carcinoma.